Regenxbio Inc (RGNX)
10.20
-0.94
(-8.48%)
USD |
NASDAQ |
Nov 15, 12:32
Regenxbio Cash and Short Term Investments (Quarterly): 255.46M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 255.46M |
| June 30, 2024 | 290.36M |
| March 31, 2024 | 338.70M |
| December 31, 2023 | 275.26M |
| September 30, 2023 | 301.89M |
| June 30, 2023 | 320.08M |
| March 31, 2023 | 331.82M |
| December 31, 2022 | 364.64M |
| September 30, 2022 | 382.42M |
| June 30, 2022 | 402.96M |
| March 31, 2022 | 394.13M |
| December 31, 2021 | 457.44M |
| September 30, 2021 | 339.86M |
| June 30, 2021 | 374.74M |
| March 31, 2021 | 440.88M |
| December 31, 2020 | 475.74M |
| September 30, 2020 | 241.52M |
| June 30, 2020 | 269.19M |
| March 31, 2020 | 279.26M |
| December 31, 2019 | 296.21M |
| Date | Value |
|---|---|
| September 30, 2019 | 331.72M |
| June 30, 2019 | 341.50M |
| March 31, 2019 | 285.22M |
| December 31, 2018 | 319.76M |
| September 30, 2018 | 372.59M |
| June 30, 2018 | 286.49M |
| March 31, 2018 | 229.87M |
| December 31, 2017 | 160.78M |
| September 30, 2017 | 166.66M |
| June 30, 2017 | 162.08M |
| March 31, 2017 | 145.81M |
| December 31, 2016 | 89.55M |
| September 30, 2016 | 91.77M |
| June 30, 2016 | 94.21M |
| March 31, 2016 | 101.06M |
| December 31, 2015 | 114.14M |
| September 30, 2015 | 213.35M |
| June 30, 2015 | 85.22M |
| December 31, 2014 | 1.121M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
241.52M
Minimum
Sep 2020
475.74M
Maximum
Dec 2020
341.63M
Average
335.26M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 442.33M |
| EyePoint Pharmaceuticals Inc | 253.79M |
| Cassava Sciences Inc | 148.98M |
| Vertex Pharmaceuticals Inc | 6.524B |
| Sarepta Therapeutics Inc | 1.198B |